Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
gut microbiota1104 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49955 | 35583480 | J Agric Food Chem | Spermidine Ameliorates Nonalcoholic Steatohepatitis through Thyroid Hormone-Responsive Protein Signaling and the Gut Microbiota-Mediated Metabolism of Bile Acids. | 2022 | Details |
| A49993 | 35568374 | Biochim Biophys Acta Mol Cell Biol Lipids | Implications of microbe-mediated crosstalk in the gut: Impact on metabolic diseases. | 2022 | Details |
| A50006 | 35565740 | Nutrients | A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients. | 2022 | Details |
| A50025 | 35559337 | Front Med (Lausanne) | The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot Study. | 2022 | Details |
| A50043 | 35548355 | Front Pharmacol | Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats. | 2022 | Details |
| A50056 | 35543143 | Food Funct | Co-interventions with Clostridium butyricum and soluble dietary fiber targeting the gut microbiota improve MAFLD via the Acly/Nrf2/NF-κB signaling pathway. | 2022 | Details |
| A50063 | 35538056 | Nat Commun | A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease. | 2022 | Details |
| A50092 | 35531334 | Front Cell Infect Microbiol | Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota. | 2022 | Details |
| A50094 | 35529918 | Evid Based Complement Alternat Med | Efficacy and Mechanism of Mallotus furetianus Müll. Arg. Extract on Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50132 | 35508444 | Eur J Intern Med | Uric acid in metabolic syndrome: Does uric acid have a definitive role? | 2022 | Details |
| A50157 | 35500802 | J Ethnopharmacol | Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice. | 2022 | Details |
| A50185 | 35485931 | J Agric Food Chem | The Ameliorating Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are SIRT1-Dependent: Evidence from Hepatic-Specific SIRT1 Heterozygous Mutant C57BL/6 Mice. | 2022 | Details |
| A50198 | 35479741 | Front Nutr | Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review. | 2022 | Details |
| A50219 | 35468693 | Front Biosci (Landmark Ed) | Quarter-Century Explorations of Bioactive Polyphenols: Diverse Health Benefits. | 2022 | Details |
| A50239 | 35462330 | Biomed Pharmacother | Update of Indoles: Promising molecules for ameliorating metabolic diseases. | 2022 | Details |
| A50292 | 35442322 | Arq Gastroenterol | PROBIOTIC, PREBIOTIC OR SYMBIOTIC SUPPLEMENTATION IMPACTS ON INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW. | 2022 | Details |
| A50296 | 35440769 | J Antibiot (Tokyo) | Triclosan targeting of gut microbiome ameliorates hepatic steatosis in high fat diet-fed mice. | 2022 | Details |
| A50348 | 35421921 | BMC Microbiol | Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus. | 2022 | Details |
| A50366 | 35416649 | J Agric Food Chem | Pterostilbene and Its Derivative 3'-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway. | 2022 | Details |
| A50391 | 35407014 | Foods | Tilapia-Head Chondroitin Sulfate Protects against Nonalcoholic Fatty Liver Disease via Modulating the Gut-Liver Axis in High-Fat-Diet-Fed C57BL/6 Mice. | 2022 | Details |
| A50416 | 35399623 | Evid Based Complement Alternat Med | Er-Chen Decoction Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Rats through Remodeling Gut Microbiota and Regulating the Serum Metabolism. | 2022 | Details |
| A50428 | 35396090 | J Pediatr Surg | The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome. | 2022 | Details |
| A50442 | 35390440 | Food Chem Toxicol | Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice. | 2022 | Details |
| A50480 | 35369480 | Front Microbiol | Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases. | 2022 | Details |
| A50514 | 35356532 | Front Cell Infect Microbiol | Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids. | 2022 | Details |
| A50526 | 35354069 | Cell Metab | Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting. | 2022 | Details |
| A50538 | 35348964 | Mol Biol Rep | Possible correlation between high circulatory levels of trimethylamine-N-oxide and 2177G>C polymorphisms of hepatic flavin containing monooxygenase 3 in Kurdish Population with non-alcoholic fatty liver disease. | 2022 | Details |
| A50599 | 35328587 | Int J Mol Sci | Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models. | 2022 | Details |
| A50620 | 35324083 | Chem Biodivers | Effect of Jiangan-Jiangzhi Pill on Gut Microbiota and Chronic Inflammatory Response in Rats with Non-Alcoholic Fatty Liver. | 2022 | Details |
| A50623 | 35323661 | Metabolites | Microbiome, Mycobiome and Related Metabolites Alterations in Patients with Metabolic Syndrome-A Pilot Study. | 2022 | Details |
| A50665 | 35308549 | Front Med (Lausanne) | Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis. | 2022 | Details |
| A50702 | 35294774 | Eur J Clin Invest | The role of microbiota in nonalcoholic fatty liver disease. | 2022 | Details |
| A50737 | 35283218 | Mol Cell Endocrinol | Discovery of farnesoid X receptor and its role in bile acid metabolism. | 2022 | Details |
| A50787 | 35266816 | mBio | Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota. | 2022 | Details |
| A51106 | 35736002 | mSystems | Identification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut. | 2022 | Details |
| A51111 | 35702368 | Int J Gen Med | Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients. | 2022 | Details |
| A51295 | 35830432 | Gut Microbes | Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters. | 2022 | Details |
| A51326 | 35601801 | Therap Adv Gastroenterol | Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis. | 2022 | Details |
| A51398 | 35814685 | Front Microbiol | Saccharomyces Boulardii Ameliorates Non-alcoholic Steatohepatitis in Mice Induced by a Methionine-Choline-Deficient Diet Through Gut-Liver Axis. | 2022 | Details |
| A51536 | 35491295 | Trends Endocrinol Metab | SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A51603 | 35740108 | Antioxidants (Basel) | The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease. | 2022 | Details |
| A51616 | 35620719 | Front Med (Lausanne) | Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant. | 2022 | Details |
| A51624 | 35508517 | Trends Endocrinol Metab | Diet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease. | 2022 | Details |
| A51625 | 35498747 | Front Vet Sci | Protective Effects of Abrus cantoniensis Hance on the Fatty Liver Hemorrhagic Syndrome in Laying Hens Based on Liver Metabolomics and Gut Microbiota. | 2022 | Details |
| A51626 | 35495929 | Front Nutr | Astaxanthin From Haematococcus pluvialis Prevents High-Fat Diet-Induced Hepatic Steatosis and Oxidative Stress in Mice by Gut-Liver Axis Modulating Properties. | 2022 | Details |
| A51669 | 35070060 | World J Diabetes | Gut microbiota-derived metabolites are novel targets for improving insulin resistance. | 2022 | Details |
| A51670 | 35070008 | World J Hepatol | Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis. | 2021 | Details |
| A51681 | 34959746 | Nutrients | Blueberry Counteracts Prediabetes in a Hypercaloric Diet-Induced Rat Model and Rescues Hepatic Mitochondrial Bioenergetics. | 2021 | Details |
| A51692 | 34896612 | Int J Biochem Cell Biol | Odd chain fatty acid metabolism in mice after a high fat diet. | 2021 | Details |
| A51701 | 34803712 | Front Pharmacol | The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. | 2021 | Details |
| A51714 | 34684436 | Nutrients | Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet. | 2021 | Details |
| A51716 | 34660695 | Front Mol Biosci | Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD. | 2021 | Details |
| A51718 | 34630882 | World J Hepatol | Probiotics in hepatology: An update. | 2021 | Details |
| A51723 | 34596865 | Hepatol Int | Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. | 2021 | Details |
| A51737 | 34460287 | Infect Immun | The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections. | 2021 | Details |
| A51758 | 34322117 | Front Immunol | The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases. | 2021 | Details |
| A51774 | 34219348 | Liver Int | Anti-TNFα treatment in Crohn's disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status. | 2021 | Details |
| A51776 | 34153347 | Food Chem Toxicol | Dietary nanoparticles alter the composition and function of the gut microbiota in mice at dose levels relevant for human exposure. | 2021 | Details |
| A51777 | 34143451 | FASEB J | Holdemanella biformis improves glucose tolerance and regulates GLP-1 signaling in obese mice. | 2021 | Details |
| A51797 | 34030573 | Gut Microbes | Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. | 2021 | Details |
| A51802 | 34007805 | J Clin Transl Hepatol | Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases. | 2021 | Details |
| A51811 | 33953584 | Diabetes Metab Syndr Obes | Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System. | 2021 | Details |
| A51812 | 33952344 | J Anim Sci Biotechnol | Short-chain fatty acids can improve lipid and glucose metabolism independently of the pig gut microbiota. | 2021 | Details |
| A51831 | 33847205 | Gut Microbes | Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns. | 2022 | Details |
| A51837 | 33809061 | Cells | Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge. | 2021 | Details |
| A51838 | 33806985 | Nutrients | Soluble Fiber Inulin Consumption Limits Alterations of the Gut Microbiota and Hepatic Fatty Acid Metabolism Caused by High-Fat Diet. | 2021 | Details |
| A51842 | 33777186 | Exp Ther Med | Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice. | 2021 | Details |
| A51848 | 33746902 | Front Endocrinol (Lausanne) | The Impact of Gut Microbiome on Metabolic Disorders During Catch-Up Growth in Small-for-Gestational-Age. | 2021 | Details |
| A51890 | 33436764 | Sci Rep | Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. | 2021 | Details |
| A51896 | 33383372 | Biomed Pharmacother | Improvements in estrogen deficiency-induced hypercholesterolemia by Hypericum perforatum L. extract are associated with gut microbiota and related metabolites in ovariectomized (OVX) rats. | 2020 | Details |
| A51915 | 33273482 | Sci Rep | NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet. | 2020 | Details |
| A51923 | 33221593 | Environ Int | Systems toxicogenomics of prenatal low-dose BPA exposure on liver metabolic pathways, gut microbiota, and metabolic health in mice. | 2020 | Details |
| A51930 | 33144308 | mSystems | Correlations between α-Linolenic Acid-Improved Multitissue Homeostasis and Gut Microbiota in Mice Fed a High-Fat Diet. | 2020 | Details |
| A51959 | 32902315 | Am J Physiol Gastrointest Liver Physiol | Effects of dietary components on intestinal permeability in health and disease. | 2020 | Details |
| A51966 | 32825248 | Nutrients | Biomarkers of Broccoli Consumption: Implications for Glutathione Metabolism and Liver Health. | 2020 | Details |
| A51979 | 32662541 | J Food Biochem | Effect of banana pulp dietary fibers on metabolic syndrome and gut microbiota diversity in high-fat diet mice. | 2020 | Details |
| A52023 | 32200644 | Am J Physiol Gastrointest Liver Physiol | Fermentable fibers induce rapid macro- and micronutrient depletion in Toll-like receptor 5-deficient mice. | 2020 | Details |
| A52058 | 31786232 | Biochimie | Vegetable lecithins: A review of their compositional diversity, impact on lipid metabolism and potential in cardiometabolic disease prevention. | 2019 | Details |
| A52104 | 31184331 | Rev Invest Clin | NUTRIGENOMICS AS A TOOL IN THE PREVENTION OF LIPOTOXICITY: THE CASE OF SOY PROTEIN. | 2019 | Details |
| A52184 | 30327643 | Front Microbiol | Alterations of Gut Microbiome in the Patients With Severe Fever With Thrombocytopenia Syndrome. | 2018 | Details |
| A52197 | 30211234 | J Immunol Res | Tributyrin Supplementation Protects Immune Responses and Vasculature and Reduces Oxidative Stress in the Proximal Colon of Mice Exposed to Chronic-Binge Ethanol Feeding. | 2018 | Details |
| A52201 | 30153290 | PLoS One | Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model. | 2018 | Details |
| A52222 | 29942089 | Nat Med | Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. | 2018 | Details |
| A52230 | 29906725 | Sci Total Environ | Chronic exposure to fungicide propamocarb induces bile acid metabolic disorder and increases trimethylamine in C57BL/6J mice. | 2018 | Details |
| A52250 | 29686404 | Nat Rev Gastroenterol Hepatol | Systems biology in hepatology: approaches and applications. | 2018 | Details |
| A52302 | 28892150 | J Pathol | Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. | 2017 | Details |
| A52329 | 28501098 | J Pediatr Surg | Alterations in intestinal microbiota relate to intestinal failure-associated liver disease and central line infections. | 2017 | Details |
| A52341 | 28393285 | Eur J Nutr | Gut microbiota functions: metabolism of nutrients and other food components. | 2017 | Details |
| A52357 | 28222147 | PLoS One | The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state. | 2017 | Details |
| A52372 | 28070463 | PeerJ | Impact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigs. | 2017 | Details |
| A52390 | 27773823 | Biochem Biophys Res Commun | Short chain fatty acids induce UCP2-mediated autophagy in hepatic cells. | 2016 | Details |
| A52416 | 29889418 | Eksp Klin Gastroenterol | METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS. | 2016 | Details |
| A52470 | 26618922 | Aliment Pharmacol Ther | Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. | 2016 | Details |
| A52496 | 26348073 | J Physiol Pharmacol | Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. | 2015 | Details |
| A52504 | 26265751 | Physiol Rep | Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats. | 2015 | Details |
| A52512 | 26197299 | Nat Commun | Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. | 2015 | Details |
| A52521 | 26098097 | PLoS One | Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice. | 2015 | Details |
| A52544 | 25749935 | J Physiol Biochem | Gut microbiota: a key player in health and disease. A review focused on obesity. | 2015 | Details |
| A52668 | 23886976 | Benef Microbes | Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. | 2014 | Details |
| A52675 | 23746045 | J Proteome Res | High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats. | 2013 | Details |